← Back to Search

Behavioral Intervention

Social Learning and Cognitive Behavioral Therapy for Irritable Bowel Syndrome (REACH Trial)

N/A

Recruiting

Research Sponsored by Seattle Children's Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 4-6 weeks, 6 months post-intervention, 12 months post-intervention, and 18 months post-intervention

Awards & highlights

REACH Trial Summary

This trial will test if a program designed to help parents with IBS teach healthy habits to their young kids is effective.

Who is the study for?

This trial is for parents over 18 with IBS who are the main caregivers of a child aged 4-6. The parent must meet ROME criteria for IBS, have been diagnosed within the last five years, and their child should live with them at least half the time. It's not for those who can't understand English, whose children have certain gastrointestinal disorders or severe chronic diseases, or lack regular internet access.Check my eligibility

What is being tested?

The REACH program's effectiveness is being tested to see if it helps parents with IBS teach their kids healthy habits. Participants will use one of two websites: one on child health/safety and another on promoting wellness behaviors. They're randomly assigned to either site and asked to complete online surveys.See study design

What are the potential side effects?

Since this trial involves educational programs delivered via websites without medical interventions, there are no direct physical side effects expected from participation in this study.

REACH Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 4-6 weeks, 6 months post-intervention, 12 months post-intervention, and 18 months post-intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 4-6 weeks, 6 months post-intervention, 12 months post-intervention, and 18 months post-intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4-6 weeks, 6 months post-intervention, 12 months post-intervention, and 18 months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in parental encouragement of child illness behavior

Secondary outcome measures

Change in abdominal pain symptoms

Change in anxiety

Change in depressive symptoms

+10 more

REACH Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Social Learning and Cognitive Behavioral Therapy (SLCBT)Experimental Treatment1 Intervention

Group II: Attention Education ControlPlacebo Group1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Social Learning and Cognitive Behavioral Therapy (SLCBT)

2003

Completed Phase 2

~200

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Seattle Children's HospitalLead Sponsor

304 Previous Clinical Trials

5,216,840 Total Patients Enrolled

University of WashingtonOTHER

1,741 Previous Clinical Trials

1,847,300 Total Patients Enrolled

5 Trials studying Irritable Bowel Syndrome

596 Patients Enrolled for Irritable Bowel Syndrome

Media Library

Social Learning and Cognitive Behavioral Therapy (SLCBT) (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05730491 — N/A

Irritable Bowel Syndrome Research Study Groups: Attention Education Control, Social Learning and Cognitive Behavioral Therapy (SLCBT)

Irritable Bowel Syndrome Clinical Trial 2023: Social Learning and Cognitive Behavioral Therapy (SLCBT) Highlights & Side Effects. Trial Name: NCT05730491 — N/A

Social Learning and Cognitive Behavioral Therapy (SLCBT) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05730491 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research currently enrolling participants?

"According to clinicaltrials.gov, this trial is not presently recruiting patients; moreover, the original posting and last edit of the study were respectively on April 1st 2023 and February 14th 2023. Nonetheless, there are still a plethora of other active trials that can be considered for enrolment at this time."

Answered by AI